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authors conclude that cryopreserved porcine allografts are at
least equivalent and possibly inferior to collagen-impregnat-
ed Dacron grafts in prevention of infection, because their
study underestimated the importance of concomitant local
and systemic antibiotic treatment at the time of allograft
implantation. The suggestion that collagen-impregnated
Dacron grafts may be more resistant to infection than cryo-
preserved allografts may be true for this porcine aortic model.
Obviously, it does not correspond to the clinical results as
mentioned. Therefore, recommendations cannot be made
from this animal study regarding how to treat established vas-
cular infection in the clinical setting. I further doubt that it
was necessary (1) to demonstrate in animals the high mortal-
ity of untreated vascular graft infection (phase I), which is
well known, and (2) to speculate about the resistance to infec-
tion of cryopreserved allografts (phase II), which is clinical-
ly proven to be safe, reproducible, and cost-effective.
Paul R. Vogt, MD, FETCS
Clinic for Cardiovascular Surgery
University Hospital
CH-8091 Zurich, Switzerland
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Studies in thoracic aortic graft infections: The
development of a porcine model and a comparison
of collagen-impregnated Dacron grafts and cryo-
preserved allografts
To the Editor:
I enjoyed reading the animal study of thoracic aortic infec-
tions by Rowe and colleagues,1 in which they examined tim-
ing of graft inoculation with staphylococci and compared the
resistance to infection between cryopreserved porcine allo-
grafts and collagen-impregnated Dacron grafts. They con-
cluded that the high morbidity and mortality of prosthetic
graft infections demands a search for improved methods of
prevention and therapy. In addition, from their animal model,
they believe that collagen-impregnated Dacron grafts were as
good as and possibly superior to cryopreserved porcine allo-
grafts in resisting infections caused by bacteremia.
This experimental setting tested whether prosthetic graft
inoculation in the presence of bacteremia leading to subse-
quent graft infection is better prevented by collagen-impreg-
nated Dacron grafts or by cryopreserved porcine allografts.
Thus, this has been a study of how to prevent infection and
not how to treat cardiovascular infection. It does not have a
relation to the surgical treatment of established native or
prosthetic aortic infection when allografts are present.
Prosthetic graft infection is a disastrous complication.
However, results have markedly improved and operative mor-
tality rates for major aortic infection have decreased to as low
as 6%2 to 13.6%.3 This improvement should be acknowl-
edged by the authors. Moreover, the 30-day mortality for tho-
racic aortic graft infection has been nearly eliminated.2
Excellent survival free of reoperation is achieved when cryo-
preserved aortic allografts are used. In my opinion, the resis-
tance to infection of cryopreserved vascular allografts is
experimentally4,5 and clinically proven. However, these rele-
vant studies2-5 were not referenced in this article.
Prevention of graft infection, as examined in this study, is
quite a different topic. The use of allografts to treat estab-
lished vascular infection must be accompanied by a simulta-
neous antibiotic treatment4 to be effective, a point that is not
considered in this study. Hence, I am not surprised that the
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